aluates Reports

$ 0.0

Automative

Global In Vivo Pharmacology Market Research Report 2024

Published Date: April 2024

Report Code: QYRE-Auto-4T12194

Global In Vivo Pharmacology Market Research Report 2022

BUY CHAPTERS

Global In Vivo Pharmacology Market Research Report 2024

Code: QYRE-Auto-4T12194

Report

April 2024

Pages:109

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

The Jackson Laboratory

Evotec AG

Pharmaron

Aurigene Pharmaceutical

Jubilant Biosys

LabCorp

Inotiv, Inc.

Takeda Pharmaceutical

Novartis

Sygnature Discovery

GenScript ProBio

ZAI LAB

Eli Lilly

EXUMA Biotech

Be Biopharma

Alderley Oncology

Sinclair Research

Gubra

In Vivo Pharmacology Market Size

The global In Vivo Pharmacology market was valued at US$ 3918.3 million in 2023 and is anticipated to reach US$ 5788.2 million by 2030, witnessing a CAGR of 5.7% during the forecast period 2024-2030.

In Vivo Pharmacology Market

In vivo pharmacology is a branch of pharmacology that focuses on the study of the effects, mechanisms of action, and safety of drugs and pharmaceutical compounds within living organisms. This field involves conducting experiments and tests on whole living organisms, such as animals (commonly rodents like mice and rats) and, in some cases, humans, to assess the pharmacological properties of drugs. In vivo studies are essential for understanding how drugs interact with biological systems, including their absorption, distribution, metabolism, and excretion (ADME), as well as their therapeutic effects and potential side effects.

Increasing Drug Development Activities: The pharmaceutical and biotechnology industries continue to expand, leading to increased demand for in vivo pharmacology services. Companies are actively developing new drugs, including those for complex diseases like cancer, autoimmune disorders, and neurodegenerative conditions, which often require extensive preclinical testing.

Increased Regulatory Scrutiny: Regulatory agencies, like the U.S. FDA and the European Medicines Agency, are continuously raising the bar for drug safety and efficacy. This has led to stricter requirements for preclinical testing, including more comprehensive and sophisticated in vivo studies.

Advancements in Animal Models: The development of more sophisticated and relevant animal models, including genetically engineered mice and patient-derived xenograft models, has enhanced the accuracy and predictive value of in vivo pharmacology studies.

Outsourcing and CRO Services: Many pharmaceutical companies are outsourcing their in vivo pharmacology studies to contract research organizations (CROs) to gain cost-efficiency, access specialized expertise, and meet timelines. This trend is expected to continue.

This report aims to provide a comprehensive presentation of the global market for In Vivo Pharmacology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In Vivo Pharmacology.

Report Scope

The In Vivo Pharmacology market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global In Vivo Pharmacology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the In Vivo Pharmacology companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of In Vivo Pharmacology Market Report

Report Metric	Details
Report Name	In Vivo Pharmacology Market
Accounted market size in 2023	US$ 3918.3 million
Forecasted market size in 2030	US$ 5788.2 million
CAGR	5.7%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Animal Disease Models Ex Vivo Pharmacology & Biomarkers PD/PK Others
Segment by Application	Ncology/Immuno-oncology Metabolic Disorders Inflammatory Diseases CNS Diseases
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Charles River, The Jackson Laboratory, Syngene, Evotec, Pharmaron, Aurigene Pharmaceutical, Jubilant Biosys, Labcorp, Inotiv, Takeda Pharmaceutical, EXUMA Biotech, Novartis, Be Biopharma, Alderley Oncology, Sygnature Discovery, GenScript ProBio, Zai Lab, Sinclair Research, Eli Lilly, Gubra
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of In Vivo Pharmacology companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is In Vivo Pharmacology Market growing?

Ans: The In Vivo Pharmacology Market witnessing a CAGR of 5.7% during the forecast period 2024-2030.

What is the In Vivo Pharmacology Market size in 2030?

Ans: The In Vivo Pharmacology Market size in 2030 will be US$ 5788.2 million.

Who are the main players in the In Vivo Pharmacology Market report?

Ans: The main players in the In Vivo Pharmacology Market are Charles River, The Jackson Laboratory, Syngene, Evotec, Pharmaron, Aurigene Pharmaceutical, Jubilant Biosys, Labcorp, Inotiv, Takeda Pharmaceutical, EXUMA Biotech, Novartis, Be Biopharma, Alderley Oncology, Sygnature Discovery, GenScript ProBio, Zai Lab, Sinclair Research, Eli Lilly, Gubra

What are the Application segmentation covered in the In Vivo Pharmacology Market report?

Ans: The Applications covered in the In Vivo Pharmacology Market report are Ncology/Immuno-oncology, Metabolic Disorders, Inflammatory Diseases, CNS Diseases

What are the Type segmentation covered in the In Vivo Pharmacology Market report?

Ans: The Types covered in the In Vivo Pharmacology Market report are Animal Disease Models, Ex Vivo Pharmacology & Biomarkers, PD/PK, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global In Vivo Pharmacology Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Animal Disease Models

1.2.3 Ex Vivo Pharmacology & Biomarkers

1.2.4 PD/PK

1.2.5 Others

1.3 Market by Application

1.3.1 Global In Vivo Pharmacology Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Ncology/Immuno-oncology

1.3.3 Metabolic Disorders

1.3.4 Inflammatory Diseases

1.3.5 CNS Diseases

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global In Vivo Pharmacology Market Perspective (2019-2030)

2.2 In Vivo Pharmacology Growth Trends by Region

2.2.1 Global In Vivo Pharmacology Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 In Vivo Pharmacology Historic Market Size by Region (2019-2024)

2.2.3 In Vivo Pharmacology Forecasted Market Size by Region (2025-2030)

2.3 In Vivo Pharmacology Market Dynamics

2.3.1 In Vivo Pharmacology Industry Trends

2.3.2 In Vivo Pharmacology Market Drivers

2.3.3 In Vivo Pharmacology Market Challenges

2.3.4 In Vivo Pharmacology Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top In Vivo Pharmacology Players by Revenue

3.1.1 Global Top In Vivo Pharmacology Players by Revenue (2019-2024)

3.1.2 Global In Vivo Pharmacology Revenue Market Share by Players (2019-2024)

3.2 Global In Vivo Pharmacology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by In Vivo Pharmacology Revenue

3.4 Global In Vivo Pharmacology Market Concentration Ratio

3.4.1 Global In Vivo Pharmacology Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by In Vivo Pharmacology Revenue in 2023

3.5 In Vivo Pharmacology Key Players Head office and Area Served

3.6 Key Players In Vivo Pharmacology Product Solution and Service

3.7 Date of Enter into In Vivo Pharmacology Market

3.8 Mergers & Acquisitions, Expansion Plans

4 In Vivo Pharmacology Breakdown Data by Type

4.1 Global In Vivo Pharmacology Historic Market Size by Type (2019-2024)

4.2 Global In Vivo Pharmacology Forecasted Market Size by Type (2025-2030)

5 In Vivo Pharmacology Breakdown Data by Application

5.1 Global In Vivo Pharmacology Historic Market Size by Application (2019-2024)

5.2 Global In Vivo Pharmacology Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America In Vivo Pharmacology Market Size (2019-2030)

6.2 North America In Vivo Pharmacology Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America In Vivo Pharmacology Market Size by Country (2019-2024)

6.4 North America In Vivo Pharmacology Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe In Vivo Pharmacology Market Size (2019-2030)

7.2 Europe In Vivo Pharmacology Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe In Vivo Pharmacology Market Size by Country (2019-2024)

7.4 Europe In Vivo Pharmacology Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific In Vivo Pharmacology Market Size (2019-2030)

8.2 Asia-Pacific In Vivo Pharmacology Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific In Vivo Pharmacology Market Size by Region (2019-2024)

8.4 Asia-Pacific In Vivo Pharmacology Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America In Vivo Pharmacology Market Size (2019-2030)

9.2 Latin America In Vivo Pharmacology Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America In Vivo Pharmacology Market Size by Country (2019-2024)

9.4 Latin America In Vivo Pharmacology Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa In Vivo Pharmacology Market Size (2019-2030)

10.2 Middle East & Africa In Vivo Pharmacology Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa In Vivo Pharmacology Market Size by Country (2019-2024)

10.4 Middle East & Africa In Vivo Pharmacology Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Charles River

11.1.1 Charles River Company Detail

11.1.2 Charles River Business Overview

11.1.3 Charles River In Vivo Pharmacology Introduction

11.1.4 Charles River Revenue in In Vivo Pharmacology Business (2019-2024)

11.1.5 Charles River Recent Development

11.2 The Jackson Laboratory

11.2.1 The Jackson Laboratory Company Detail

11.2.2 The Jackson Laboratory Business Overview

11.2.3 The Jackson Laboratory In Vivo Pharmacology Introduction

11.2.4 The Jackson Laboratory Revenue in In Vivo Pharmacology Business (2019-2024)

11.2.5 The Jackson Laboratory Recent Development

11.3 Syngene

11.3.1 Syngene Company Detail

11.3.2 Syngene Business Overview

11.3.3 Syngene In Vivo Pharmacology Introduction

11.3.4 Syngene Revenue in In Vivo Pharmacology Business (2019-2024)

11.3.5 Syngene Recent Development

11.4 Evotec

11.4.1 Evotec Company Detail

11.4.2 Evotec Business Overview

11.4.3 Evotec In Vivo Pharmacology Introduction

11.4.4 Evotec Revenue in In Vivo Pharmacology Business (2019-2024)

11.4.5 Evotec Recent Development

11.5 Pharmaron

11.5.1 Pharmaron Company Detail

11.5.2 Pharmaron Business Overview

11.5.3 Pharmaron In Vivo Pharmacology Introduction

11.5.4 Pharmaron Revenue in In Vivo Pharmacology Business (2019-2024)

11.5.5 Pharmaron Recent Development

11.6 Aurigene Pharmaceutical

11.6.1 Aurigene Pharmaceutical Company Detail

11.6.2 Aurigene Pharmaceutical Business Overview

11.6.3 Aurigene Pharmaceutical In Vivo Pharmacology Introduction

11.6.4 Aurigene Pharmaceutical Revenue in In Vivo Pharmacology Business (2019-2024)

11.6.5 Aurigene Pharmaceutical Recent Development

11.7 Jubilant Biosys

11.7.1 Jubilant Biosys Company Detail

11.7.2 Jubilant Biosys Business Overview

11.7.3 Jubilant Biosys In Vivo Pharmacology Introduction

11.7.4 Jubilant Biosys Revenue in In Vivo Pharmacology Business (2019-2024)

11.7.5 Jubilant Biosys Recent Development

11.8 Labcorp

11.8.1 Labcorp Company Detail

11.8.2 Labcorp Business Overview

11.8.3 Labcorp In Vivo Pharmacology Introduction

11.8.4 Labcorp Revenue in In Vivo Pharmacology Business (2019-2024)

11.8.5 Labcorp Recent Development

11.9 Inotiv

11.9.1 Inotiv Company Detail

11.9.2 Inotiv Business Overview

11.9.3 Inotiv In Vivo Pharmacology Introduction

11.9.4 Inotiv Revenue in In Vivo Pharmacology Business (2019-2024)

11.9.5 Inotiv Recent Development

11.10 Takeda Pharmaceutical

11.10.1 Takeda Pharmaceutical Company Detail

11.10.2 Takeda Pharmaceutical Business Overview

11.10.3 Takeda Pharmaceutical In Vivo Pharmacology Introduction

11.10.4 Takeda Pharmaceutical Revenue in In Vivo Pharmacology Business (2019-2024)

11.10.5 Takeda Pharmaceutical Recent Development

11.11 EXUMA Biotech

11.11.1 EXUMA Biotech Company Detail

11.11.2 EXUMA Biotech Business Overview

11.11.3 EXUMA Biotech In Vivo Pharmacology Introduction

11.11.4 EXUMA Biotech Revenue in In Vivo Pharmacology Business (2019-2024)

11.11.5 EXUMA Biotech Recent Development

11.12 Novartis

11.12.1 Novartis Company Detail

11.12.2 Novartis Business Overview

11.12.3 Novartis In Vivo Pharmacology Introduction

11.12.4 Novartis Revenue in In Vivo Pharmacology Business (2019-2024)

11.12.5 Novartis Recent Development

11.13 Be Biopharma

11.13.1 Be Biopharma Company Detail

11.13.2 Be Biopharma Business Overview

11.13.3 Be Biopharma In Vivo Pharmacology Introduction

11.13.4 Be Biopharma Revenue in In Vivo Pharmacology Business (2019-2024)

11.13.5 Be Biopharma Recent Development

11.14 Alderley Oncology

11.14.1 Alderley Oncology Company Detail

11.14.2 Alderley Oncology Business Overview

11.14.3 Alderley Oncology In Vivo Pharmacology Introduction

11.14.4 Alderley Oncology Revenue in In Vivo Pharmacology Business (2019-2024)

11.14.5 Alderley Oncology Recent Development

11.15 Sygnature Discovery

11.15.1 Sygnature Discovery Company Detail

11.15.2 Sygnature Discovery Business Overview

11.15.3 Sygnature Discovery In Vivo Pharmacology Introduction

11.15.4 Sygnature Discovery Revenue in In Vivo Pharmacology Business (2019-2024)

11.15.5 Sygnature Discovery Recent Development

11.16 GenScript ProBio

11.16.1 GenScript ProBio Company Detail

11.16.2 GenScript ProBio Business Overview

11.16.3 GenScript ProBio In Vivo Pharmacology Introduction

11.16.4 GenScript ProBio Revenue in In Vivo Pharmacology Business (2019-2024)

11.16.5 GenScript ProBio Recent Development

11.17 Zai Lab

11.17.1 Zai Lab Company Detail

11.17.2 Zai Lab Business Overview

11.17.3 Zai Lab In Vivo Pharmacology Introduction

11.17.4 Zai Lab Revenue in In Vivo Pharmacology Business (2019-2024)

11.17.5 Zai Lab Recent Development

11.18 Sinclair Research

11.18.1 Sinclair Research Company Detail

11.18.2 Sinclair Research Business Overview

11.18.3 Sinclair Research In Vivo Pharmacology Introduction

11.18.4 Sinclair Research Revenue in In Vivo Pharmacology Business (2019-2024)

11.18.5 Sinclair Research Recent Development

11.19 Eli Lilly

11.19.1 Eli Lilly Company Detail

11.19.2 Eli Lilly Business Overview

11.19.3 Eli Lilly In Vivo Pharmacology Introduction

11.19.4 Eli Lilly Revenue in In Vivo Pharmacology Business (2019-2024)

11.19.5 Eli Lilly Recent Development

11.20 Gubra

11.20.1 Gubra Company Detail

11.20.2 Gubra Business Overview

11.20.3 Gubra In Vivo Pharmacology Introduction

11.20.4 Gubra Revenue in In Vivo Pharmacology Business (2019-2024)

11.20.5 Gubra Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

The Jackson Laboratory

Evotec AG

Pharmaron

Aurigene Pharmaceutical

Jubilant Biosys

LabCorp

Inotiv, Inc.

Takeda Pharmaceutical

Novartis

Sygnature Discovery

GenScript ProBio

ZAI LAB

Eli Lilly

EXUMA Biotech

Be Biopharma

Alderley Oncology

Sinclair Research

Gubra

List of Tables

Table 1. Global In Vivo Pharmacology Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Animal Disease Models

Table 3. Key Players of Ex Vivo Pharmacology & Biomarkers

Table 4. Key Players of PD/PK

Table 5. Key Players of Others

Table 6. Global In Vivo Pharmacology Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global In Vivo Pharmacology Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global In Vivo Pharmacology Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global In Vivo Pharmacology Market Share by Region (2019-2024)

Table 10. Global In Vivo Pharmacology Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global In Vivo Pharmacology Market Share by Region (2025-2030)

Table 12. In Vivo Pharmacology Market Trends

Table 13. In Vivo Pharmacology Market Drivers

Table 14. In Vivo Pharmacology Market Challenges

Table 15. In Vivo Pharmacology Market Restraints

Table 16. Global In Vivo Pharmacology Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global In Vivo Pharmacology Market Share by Players (2019-2024)

Table 18. Global Top In Vivo Pharmacology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vivo Pharmacology as of 2023)

Table 19. Ranking of Global Top In Vivo Pharmacology Companies by Revenue (US$ Million) in 2023

Table 20. Global 5 Largest Players Market Share by In Vivo Pharmacology Revenue (CR5 and HHI) & (2019-2024)

Table 21. Key Players Headquarters and Area Served

Table 22. Key Players In Vivo Pharmacology Product Solution and Service

Table 23. Date of Enter into In Vivo Pharmacology Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global In Vivo Pharmacology Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global In Vivo Pharmacology Revenue Market Share by Type (2019-2024)

Table 27. Global In Vivo Pharmacology Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global In Vivo Pharmacology Revenue Market Share by Type (2025-2030)

Table 29. Global In Vivo Pharmacology Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global In Vivo Pharmacology Revenue Market Share by Application (2019-2024)

Table 31. Global In Vivo Pharmacology Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global In Vivo Pharmacology Revenue Market Share by Application (2025-2030)

Table 33. North America In Vivo Pharmacology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 34. North America In Vivo Pharmacology Market Size by Country (2019-2024) & (US$ Million)

Table 35. North America In Vivo Pharmacology Market Size by Country (2025-2030) & (US$ Million)

Table 36. Europe In Vivo Pharmacology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. Europe In Vivo Pharmacology Market Size by Country (2019-2024) & (US$ Million)

Table 38. Europe In Vivo Pharmacology Market Size by Country (2025-2030) & (US$ Million)

Table 39. Asia-Pacific In Vivo Pharmacology Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 40. Asia-Pacific In Vivo Pharmacology Market Size by Region (2019-2024) & (US$ Million)

Table 41. Asia-Pacific In Vivo Pharmacology Market Size by Region (2025-2030) & (US$ Million)

Table 42. Latin America In Vivo Pharmacology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Latin America In Vivo Pharmacology Market Size by Country (2019-2024) & (US$ Million)

Table 44. Latin America In Vivo Pharmacology Market Size by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa In Vivo Pharmacology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Middle East & Africa In Vivo Pharmacology Market Size by Country (2019-2024) & (US$ Million)

Table 47. Middle East & Africa In Vivo Pharmacology Market Size by Country (2025-2030) & (US$ Million)

Table 48. Charles River Company Detail

Table 49. Charles River Business Overview

Table 50. Charles River In Vivo Pharmacology Product

Table 51. Charles River Revenue in In Vivo Pharmacology Business (2019-2024) & (US$ Million)

Table 52. Charles River Recent Development

Table 53. The Jackson Laboratory Company Detail

Table 54. The Jackson Laboratory Business Overview

Table 55. The Jackson Laboratory In Vivo Pharmacology Product

Table 56. The Jackson Laboratory Revenue in In Vivo Pharmacology Business (2019-2024) & (US$ Million)

Table 57. The Jackson Laboratory Recent Development

Table 58. Syngene Company Detail

Table 59. Syngene Business Overview

Table 60. Syngene In Vivo Pharmacology Product

Table 61. Syngene Revenue in In Vivo Pharmacology Business (2019-2024) & (US$ Million)

Table 62. Syngene Recent Development

Table 63. Evotec Company Detail

Table 64. Evotec Business Overview

Table 65. Evotec In Vivo Pharmacology Product

Table 66. Evotec Revenue in In Vivo Pharmacology Business (2019-2024) & (US$ Million)

Table 67. Evotec Recent Development

Table 68. Pharmaron Company Detail

Table 69. Pharmaron Business Overview

Table 70. Pharmaron In Vivo Pharmacology Product

Table 71. Pharmaron Revenue in In Vivo Pharmacology Business (2019-2024) & (US$ Million)

Table 72. Pharmaron Recent Development

Table 73. Aurigene Pharmaceutical Company Detail

Table 74. Aurigene Pharmaceutical Business Overview

Table 75. Aurigene Pharmaceutical In Vivo Pharmacology Product

Table 76. Aurigene Pharmaceutical Revenue in In Vivo Pharmacology Business (2019-2024) & (US$ Million)

Table 77. Aurigene Pharmaceutical Recent Development

Table 78. Jubilant Biosys Company Detail

Table 79. Jubilant Biosys Business Overview

Table 80. Jubilant Biosys In Vivo Pharmacology Product

Table 81. Jubilant Biosys Revenue in In Vivo Pharmacology Business (2019-2024) & (US$ Million)

Table 82. Jubilant Biosys Recent Development

Table 83. Labcorp Company Detail

Table 84. Labcorp Business Overview

Table 85. Labcorp In Vivo Pharmacology Product

Table 86. Labcorp Revenue in In Vivo Pharmacology Business (2019-2024) & (US$ Million)

Table 87. Labcorp Recent Development

Table 88. Inotiv Company Detail

Table 89. Inotiv Business Overview

Table 90. Inotiv In Vivo Pharmacology Product

Table 91. Inotiv Revenue in In Vivo Pharmacology Business (2019-2024) & (US$ Million)

Table 92. Inotiv Recent Development

Table 93. Takeda Pharmaceutical Company Detail

Table 94. Takeda Pharmaceutical Business Overview

Table 95. Takeda Pharmaceutical In Vivo Pharmacology Product

Table 96. Takeda Pharmaceutical Revenue in In Vivo Pharmacology Business (2019-2024) & (US$ Million)

Table 97. Takeda Pharmaceutical Recent Development

Table 98. EXUMA Biotech Company Detail

Table 99. EXUMA Biotech Business Overview

Table 100. EXUMA Biotech In Vivo Pharmacology Product

Table 101. EXUMA Biotech Revenue in In Vivo Pharmacology Business (2019-2024) & (US$ Million)

Table 102. EXUMA Biotech Recent Development

Table 103. Novartis Company Detail

Table 104. Novartis Business Overview

Table 105. Novartis In Vivo Pharmacology Product

Table 106. Novartis Revenue in In Vivo Pharmacology Business (2019-2024) & (US$ Million)

Table 107. Novartis Recent Development

Table 108. Be Biopharma Company Detail

Table 109. Be Biopharma Business Overview

Table 110. Be Biopharma In Vivo Pharmacology Product

Table 111. Be Biopharma Revenue in In Vivo Pharmacology Business (2019-2024) & (US$ Million)

Table 112. Be Biopharma Recent Development

Table 113. Alderley Oncology Company Detail

Table 114. Alderley Oncology Business Overview

Table 115. Alderley Oncology In Vivo Pharmacology Product

Table 116. Alderley Oncology Revenue in In Vivo Pharmacology Business (2019-2024) & (US$ Million)

Table 117. Alderley Oncology Recent Development

Table 118. Sygnature Discovery Company Detail

Table 119. Sygnature Discovery Business Overview

Table 120. Sygnature Discovery In Vivo Pharmacology Product

Table 121. Sygnature Discovery Revenue in In Vivo Pharmacology Business (2019-2024) & (US$ Million)

Table 122. Sygnature Discovery Recent Development

Table 123. GenScript ProBio Company Detail

Table 124. GenScript ProBio Business Overview

Table 125. GenScript ProBio In Vivo Pharmacology Product

Table 126. GenScript ProBio Revenue in In Vivo Pharmacology Business (2019-2024) & (US$ Million)

Table 127. GenScript ProBio Recent Development

Table 128. Zai Lab Company Detail

Table 129. Zai Lab Business Overview

Table 130. Zai Lab In Vivo Pharmacology Product

Table 131. Zai Lab Revenue in In Vivo Pharmacology Business (2019-2024) & (US$ Million)

Table 132. Zai Lab Recent Development

Table 133. Sinclair Research Company Detail

Table 134. Sinclair Research Business Overview

Table 135. Sinclair Research In Vivo Pharmacology Product

Table 136. Sinclair Research Revenue in In Vivo Pharmacology Business (2019-2024) & (US$ Million)

Table 137. Sinclair Research Recent Development

Table 138. Eli Lilly Company Detail

Table 139. Eli Lilly Business Overview

Table 140. Eli Lilly In Vivo Pharmacology Product

Table 141. Eli Lilly Revenue in In Vivo Pharmacology Business (2019-2024) & (US$ Million)

Table 142. Eli Lilly Recent Development

Table 143. Gubra Company Detail

Table 144. Gubra Business Overview

Table 145. Gubra In Vivo Pharmacology Product

Table 146. Gubra Revenue in In Vivo Pharmacology Business (2019-2024) & (US$ Million)

Table 147. Gubra Recent Development

Table 148. Research Programs/Design for This Report

Table 149. Key Data Information from Secondary Sources

Table 150. Key Data Information from Primary Sources

List of Figures

Figure 1. Global In Vivo Pharmacology Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global In Vivo Pharmacology Market Share by Type: 2023 VS 2030

Figure 3. Animal Disease Models Features

Figure 4. Ex Vivo Pharmacology & Biomarkers Features

Figure 5. PD/PK Features

Figure 6. Others Features

Figure 7. Global In Vivo Pharmacology Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global In Vivo Pharmacology Market Share by Application: 2023 VS 2030

Figure 9. Ncology/Immuno-oncology Case Studies

Figure 10. Metabolic Disorders Case Studies

Figure 11. Inflammatory Diseases Case Studies

Figure 12. CNS Diseases Case Studies

Figure 13. In Vivo Pharmacology Report Years Considered

Figure 14. Global In Vivo Pharmacology Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global In Vivo Pharmacology Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global In Vivo Pharmacology Market Share by Region: 2023 VS 2030

Figure 17. Global In Vivo Pharmacology Market Share by Players in 2023

Figure 18. Global Top In Vivo Pharmacology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vivo Pharmacology as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by In Vivo Pharmacology Revenue in 2023

Figure 20. North America In Vivo Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America In Vivo Pharmacology Market Share by Country (2019-2030)

Figure 22. United States In Vivo Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada In Vivo Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe In Vivo Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe In Vivo Pharmacology Market Share by Country (2019-2030)

Figure 26. Germany In Vivo Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. France In Vivo Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. U.K. In Vivo Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Italy In Vivo Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Russia In Vivo Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Nordic Countries In Vivo Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific In Vivo Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific In Vivo Pharmacology Market Share by Region (2019-2030)

Figure 34. China In Vivo Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Japan In Vivo Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. South Korea In Vivo Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Southeast Asia In Vivo Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. India In Vivo Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Australia In Vivo Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America In Vivo Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America In Vivo Pharmacology Market Share by Country (2019-2030)

Figure 42. Mexico In Vivo Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Brazil In Vivo Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa In Vivo Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa In Vivo Pharmacology Market Share by Country (2019-2030)

Figure 46. Turkey In Vivo Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Saudi Arabia In Vivo Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Charles River Revenue Growth Rate in In Vivo Pharmacology Business (2019-2024)

Figure 49. The Jackson Laboratory Revenue Growth Rate in In Vivo Pharmacology Business (2019-2024)

Figure 50. Syngene Revenue Growth Rate in In Vivo Pharmacology Business (2019-2024)

Figure 51. Evotec Revenue Growth Rate in In Vivo Pharmacology Business (2019-2024)

Figure 52. Pharmaron Revenue Growth Rate in In Vivo Pharmacology Business (2019-2024)

Figure 53. Aurigene Pharmaceutical Revenue Growth Rate in In Vivo Pharmacology Business (2019-2024)

Figure 54. Jubilant Biosys Revenue Growth Rate in In Vivo Pharmacology Business (2019-2024)

Figure 55. Labcorp Revenue Growth Rate in In Vivo Pharmacology Business (2019-2024)

Figure 56. Inotiv Revenue Growth Rate in In Vivo Pharmacology Business (2019-2024)

Figure 57. Takeda Pharmaceutical Revenue Growth Rate in In Vivo Pharmacology Business (2019-2024)

Figure 58. EXUMA Biotech Revenue Growth Rate in In Vivo Pharmacology Business (2019-2024)

Figure 59. Novartis Revenue Growth Rate in In Vivo Pharmacology Business (2019-2024)

Figure 60. Be Biopharma Revenue Growth Rate in In Vivo Pharmacology Business (2019-2024)

Figure 61. Alderley Oncology Revenue Growth Rate in In Vivo Pharmacology Business (2019-2024)

Figure 62. Sygnature Discovery Revenue Growth Rate in In Vivo Pharmacology Business (2019-2024)

Figure 63. GenScript ProBio Revenue Growth Rate in In Vivo Pharmacology Business (2019-2024)

Figure 64. Zai Lab Revenue Growth Rate in In Vivo Pharmacology Business (2019-2024)

Figure 65. Sinclair Research Revenue Growth Rate in In Vivo Pharmacology Business (2019-2024)

Figure 66. Eli Lilly Revenue Growth Rate in In Vivo Pharmacology Business (2019-2024)

Figure 67. Gubra Revenue Growth Rate in In Vivo Pharmacology Business (2019-2024)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions